News – Page 114 – Endpoints News

TIGIT drugs take another hit as Merck stops Phase 3 lung cancer trial for futility

9 months ago

Q&A: PhRMA CEO Stephen Ubl on the IRA, challenges to the FDA’s authority and the US-China relationship

9 months ago

Roivant to 'unveil' pipeline addition next month; Bavarian Nordic gets $156M from US

9 months ago

Updated: Recursion to acquire Exscientia to bolster pipeline in one of AI bio’s biggest M&A deals

9 months ago

Entero Therapeutics turns the lights off as creditors come calling

9 months ago

Lilly crushes expectations with GLP-1 franchise, as supply constraints ease

9 months ago

UK's NHS, Vertex strike pact, accelerating Casgevy rollout in beta thalassemia

9 months ago

FDA approves Novartis’ complement inhibitor Fabhalta for rare kidney disease

9 months ago

Sanofi’s Sarclisa scores in Phase 3 transplant-eligible multiple myeloma test

9 months ago

Sarepta faces lower revenue for Duchenne gene therapy ahead of expected sales jump with expanded treatment label

9 months ago

Oscar Health's guidance gets a boost from ex-Medicaid members

9 months ago

Health insurers are covering fewer telehealth companies, Talkspace says

9 months ago

FDA reprimands Bristol Myers over misleading efficacy claims on Krazati website

9 months ago

UPenn sues BioNTech, says it owes 'significant' Covid-related royalties

9 months ago

Big drugmakers have cut outside R&D spending amid broad pullback, key contractor warns

9 months ago

FDA grapples with its role in AI, and how to guide industry's adoption

9 months ago

CVS ousts Aetna president as it tries to fix its health insurance business

9 months ago

IDRx raises $120M for targeted GIST drug following leadership change

9 months ago

Stoke Therapeutics’ partial hold lifted; Recursion gets $30M from Roche

9 months ago

Pfizer got a $1.2B payout for its stake in Cerevel

9 months ago

Pfizer invests $98M in Australian manufacturing to help develop new antimicrobial treatments

9 months ago

Inspection delays hold back BeiGene's Tevimbra progress once again

9 months ago

Private Danish iron deficiency biotech to buy G1 Therapeutics for $405M

9 months ago

Updated: Madrigal finally reveals first wave of sales for MASH drug Rezdiffra

9 months ago

First page Previous page 111 112 113114115 116 117 Next page Last page